{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T06:52:12Z","timestamp":1789887132892,"version":"4.0.1"},"reference-count":35,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2018,5,16]],"date-time":"2018-05-16T00:00:00Z","timestamp":1526428800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2018,5,16]],"date-time":"2018-05-16T00:00:00Z","timestamp":1526428800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Biofrontera Bioscience GmbH"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Dermatol"],"DOI":"10.1111\/bjd.16441","type":"journal-article","created":{"date-parts":[[2018,2,12]],"date-time":"2018-02-12T19:56:42Z","timestamp":1518465402000},"source":"Crossref","is-referenced-by-count":40,"title":["A randomized, multinational, noninferiority, phase III trial to evaluate the safety and efficacy of BF-200 aminolaevulinic acid gel vs. methyl aminolaevulinate cream in the treatment of nonaggressive basal cell carcinoma with photodynamic therapy"],"prefix":"10.1093","author":[{"given":"C.A.","family":"Morton","sequence":"first","affiliation":[{"name":"Dermatology Department; Stirling Community Hospital; NHS Forth Valley; Stirling U.K"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Dominicus","sequence":"additional","affiliation":[{"name":"ProDerma; D\u00fclmen Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Radny","sequence":"additional","affiliation":[{"name":"Private Dermatological Practice; Friedrichshafen Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Dirschka","sequence":"additional","affiliation":[{"name":"CentroDerm GmbH, Wuppertal, and Faculty of Health; University Witten\/Herdecke; Witten Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Hauschild","sequence":"additional","affiliation":[{"name":"Dermatologikum Kiel and Department of Dermatology; University Hospital Schleswig-Holstein (UKSH); Kiel Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Reinhold","sequence":"additional","affiliation":[{"name":"Medical Centre Bonn; Bonn Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Aschoff","sequence":"additional","affiliation":[{"name":"Department of Dermatology; University Hospital Carl Gustav Carus; Technical University Dresden; Dresden Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Ulrich","sequence":"additional","affiliation":[{"name":"CMB Collegium Medicum Berlin GmbH; Berlin Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Keohane","sequence":"additional","affiliation":[{"name":"St Mary's Hospital; Portsmouth Dermatology Centre; NHS Trust; Portsmouth U.K"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Ekanayake-Bohlig","sequence":"additional","affiliation":[{"name":"MENSINGDERMA research GmbH; Hamburg Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Ibbotson","sequence":"additional","affiliation":[{"name":"Photobiology Unit; University of Dundee; Ninewells Hospital and Medical School; Dundee U.K"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Ostendorf","sequence":"additional","affiliation":[{"name":"ZENTderma; M\u00f6nchengladbach Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Berking","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Allergology; University Hospital Munich; Munich Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Gr\u00f6ne","sequence":"additional","affiliation":[{"name":"Dermatological Private Practice; Clinical Research and Laser Medicine; Berlin Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.J.","family":"Schulze","sequence":"additional","affiliation":[{"name":"Specialist Hospital Hornheide; Department of Dermatology; M\u00fcnster Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.M.","family":"Ockenfels","sequence":"additional","affiliation":[{"name":"Dermatology and Allergology Practice at the Clinical Centre Hanau; Hanau Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Jasnoch","sequence":"additional","affiliation":[{"name":"Centre for Dermatology Vechta; Vechta Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Kurzen","sequence":"additional","affiliation":[{"name":"Private Practice; Freising Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Sebastian","sequence":"additional","affiliation":[{"name":"Private Practice; Mahlow Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Stege","sequence":"additional","affiliation":[{"name":"Department of Dermatology; Clinical Centre Lippe GmbH Detmold; Detmold Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Staubach","sequence":"additional","affiliation":[{"name":"Department of Dermatology; University Hospital Johannes Gutenberg University Mainz; Clinical Research Center; Mainz Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Gupta","sequence":"additional","affiliation":[{"name":"Monklands Hospital; NHS Lanarkshire; Airdrie and University of Glasgow; Glasgow U.K"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"H\u00fcbinger","sequence":"additional","affiliation":[{"name":"Private Practice; Wuppertal Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Ziabreva","sequence":"additional","affiliation":[{"name":"Clinipace - Accovion GmbH; Eschborn Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Schmitz","sequence":"additional","affiliation":[{"name":"Biofrontera Bioscience GmbH; Leverkusen Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Gertzmann","sequence":"additional","affiliation":[{"name":"Biofrontera Bioscience GmbH; Leverkusen Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"L\u00fcbbert","sequence":"additional","affiliation":[{"name":"Biofrontera Bioscience GmbH; Leverkusen Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.-M.","family":"Szeimies","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Allergology; Vest Clinic; Recklinghausen Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,5,16]]},"reference":[{"key":"10.1111\/bjd.16441-BIB0001|bjd16441-cit-0001","volume-title":"Pathology and Genetics of Skin Tumours. World Health Organization Classification of Tumours","author":"LeBoit","year":"2006"},{"key":"10.1111\/bjd.16441-BIB0002|bjd16441-cit-0002","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1023\/B:CANC.0000031775.04618.30","article-title":"Aggressive basal cell carcinoma: presentation, pathogenesis, and management","volume":"23","author":"Walling","year":"2004","journal-title":"Cancer Metastasis Rev"},{"issue":"Suppl. 3","key":"10.1111\/bjd.16441-BIB0003|bjd16441-cit-0003","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2133.2007.07861.x","article-title":"Epidemiology of nonmelanoma skin cancer (NMSC) in Europe: accurate and comparable data are needed for effective public health monitoring and interventions","volume":"156","author":"Trakatelli","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.16441-BIB0004|bjd16441-cit-0004","first-page":"1105","article-title":"Changes in nonmelanoma skin cancer incidence between 1977-1978 and 1998-1999 in Northcentral New Mexico","volume":"12","author":"Athas","year":"2003","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1111\/bjd.16441-BIB0005|bjd16441-cit-0005","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1684\/ejd.2014.2271","article-title":"Update of the European guidelines for basal cell carcinoma management","volume":"24","author":"Trakatelli","year":"2014","journal-title":"Eur J Dermatol"},{"key":"10.1111\/bjd.16441-BIB0006|bjd16441-cit-0006","doi-asserted-by":"crossref","first-page":"24","DOI":"10.2340\/00015555-1009","article-title":"Incidence, prevalence and future trends of primary basal cell carcinoma in the Netherlands","volume":"91","author":"Flohil","year":"2011","journal-title":"Acta Derm Venereol"},{"key":"10.1111\/bjd.16441-BIB0007|bjd16441-cit-0007","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/ajd.12282","article-title":"Incidence and prevalence of non-melanoma skin cancer in Australia: a systematic review","volume":"56","author":"Perera","year":"2015","journal-title":"Australas J Dermatol"},{"key":"10.1111\/bjd.16441-BIB0008|bjd16441-cit-0008","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1365-2133.2008.08666.x","article-title":"Guidelines for the management of basal cell carcinoma","volume":"159","author":"Telfer","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.16441-BIB0009|bjd16441-cit-0009","first-page":"394","article-title":"Management of basal cell carcinoma in adults: clinical practice guidelines","volume":"16","author":"Dandurand","year":"2006","journal-title":"Eur J Dermatol"},{"key":"10.1111\/bjd.16441-BIB0010|bjd16441-cit-0010","first-page":"20","article-title":"An update on nonmelanoma skin cancer","volume":"4","author":"Patel","year":"2011","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1111\/bjd.16441-BIB0011|bjd16441-cit-0011","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/j.1365-2133.2012.11061.x","article-title":"Overall treatment success after treatment of primary superficial basal cell carcinoma: a systematic review and meta-analysis of randomized and non-randomized trials","volume":"167","author":"Roozeboom","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.16441-BIB0012|bjd16441-cit-0012","first-page":"319","article-title":"Photodynamic therapy for large or multiple patches of Bowen disease and basal cell carcinoma","volume":"137","author":"Morton","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.16441-BIB0013|bjd16441-cit-0013","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.det.2006.09.005","article-title":"Aminolevulinic acid photodynamic therapy for skin cancers","volume":"25","author":"Blume","year":"2007","journal-title":"Dermatol Clin"},{"key":"10.1111\/bjd.16441-BIB0014|bjd16441-cit-0014","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jaad.2013.02.014","article-title":"Fractionated 5-aminolevulinic acid photodynamic therapy after partial debulking versus surgical excision for nodular basal cell carcinoma: a randomized controlled trial with at least 5-year follow-up","volume":"69","author":"Roozeboom","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.16441-BIB0015|bjd16441-cit-0015","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1046\/j.1365-2133.2001.04141.x","article-title":"Photodynamic therapy vs. cryosurgery of basal cell carcinomas: results of a phase III clinical trial","volume":"144","author":"Wang","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.16441-BIB0016|bjd16441-cit-0016","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1001\/archderm.143.9.1131","article-title":"Five-year follow-up of a randomized, prospective trial of topical methyl aminolevulinate photodynamic therapy versus surgery for nodular basal cell carcinoma","volume":"143","author":"Rhodes","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.16441-BIB0017|bjd16441-cit-0017","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1111\/j.1365-2133.2008.08787.x","article-title":"Fractionated 5-aminolaevulinic acid-photodynamic therapy vs. surgical excision in the treatment of nodular basal cell carcinoma: results of a randomized controlled trial","volume":"159","author":"Mosterd","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.16441-BIB0018|bjd16441-cit-0018","first-page":"642","article-title":"Similar effectiveness of methyl aminolevulinate and 5-aminolevulinate in topical photodynamic therapy for nodular basal cell carcinoma","volume":"5","author":"Kuijpers","year":"2006","journal-title":"J Drugs Dermatol"},{"key":"10.1111\/bjd.16441-BIB0019|bjd16441-cit-0019","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.det.2006.09.008","article-title":"Methyl aminolevulinate-photodynamic therapy for basal cell carcinoma","volume":"25","author":"Szeimies","year":"2007","journal-title":"Dermatol Clin"},{"key":"10.1111\/bjd.16441-BIB0020|bjd16441-cit-0020","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1111\/j.1468-3083.2008.02803.x","article-title":"A clinical study comparing methyl aminolevulinate photodynamic therapy and surgery in small superficial basal cell carcinoma (8-20 mm), with a 12-month follow-up","volume":"22","author":"Szeimies","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/bjd.16441-BIB0021|bjd16441-cit-0021","doi-asserted-by":"crossref","first-page":"e302","DOI":"10.1111\/j.1600-0625.2009.01001.x","article-title":"Fluorescence induction of protoporphyrin IX by a new 5-aminolevulinic acid nanoemulsion used for photodynamic therapy in a full-thickness ex vivo skin model","volume":"19","author":"Maisch","year":"2010","journal-title":"Exp Dermatol"},{"key":"10.1111\/bjd.16441-BIB0022|bjd16441-cit-0022","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.pdpdt.2015.11.004","article-title":"Epidermal penetration and protoporphyrin IX formation of two different 5-aminolevulinic acid formulations in ex vivo human skin","volume":"14","author":"Schmitz","year":"2016","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"10.1111\/bjd.16441-BIB0023|bjd16441-cit-0023","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1001\/archderm.140.1.17","article-title":"Photodynamic therapy using topical methyl aminolevulinate versus surgery for nodular basal cell carcinoma: results of a multicenter randomized prospective trial","volume":"140","author":"Rhodes","year":"2004","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.16441-BIB0024|bjd16441-cit-0024","first-page":"547","article-title":"Topical methyl aminolaevulinate photodynamic therapy versus cryotherapy for superficial basal cell carcinoma: a 5 year randomized trial","volume":"18","author":"Basset-Seguin","year":"2008","journal-title":"Eur J Dermatol"},{"issue":"Suppl. 3","key":"10.1111\/bjd.16441-BIB0025|bjd16441-cit-0025","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/jdt.14.s3.15.22","article-title":"Clinical efficacy of methyl aminolevulinate (Metvix) photodynamic therapy","volume":"14","author":"Foley","year":"2003","journal-title":"J Dermatolog Treat"},{"key":"10.1111\/bjd.16441-BIB0026|bjd16441-cit-0026","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/1011-1344(90)85083-9","article-title":"Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience","volume":"6","author":"Kennedy","year":"1990","journal-title":"J Photochem Photobiol B"},{"key":"10.1111\/bjd.16441-BIB0027|bjd16441-cit-0027","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s00210-012-0777-4","article-title":"Comparison of the uptake of 5-aminolevulinic acid and its methyl ester in keratinocytes and skin","volume":"385","author":"Schulten","year":"2012","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1111\/bjd.16441-BIB0028|bjd16441-cit-0028","doi-asserted-by":"crossref","first-page":"250","DOI":"10.3322\/caac.20114","article-title":"Photodynamic therapy of cancer: an update","volume":"61","author":"Agostinis","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"10.1111\/bjd.16441-BIB0029|bjd16441-cit-0029","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1159\/000018006","article-title":"Photodynamic therapy of superficial basal cell carcinomas using topical 5-aminolevulinic acid in a nanocolloid lotion","volume":"197","author":"Hurlimann","year":"1998","journal-title":"Dermatology"},{"key":"10.1111\/bjd.16441-BIB0030|bjd16441-cit-0030","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1111\/bjd.14498","article-title":"A randomized, double-blind, phase III, multicentre study to evaluate the safety and efficacy of BF-200 ALA (Ameluz\u00ae) vs. placebo in the field-directed treatment of mild-to-moderate actinic keratosis with photodynamic therapy (PDT) when using the BF-RhodoLED\u00ae lamp","volume":"175","author":"Reinhold","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.16441-BIB0031|bjd16441-cit-0031","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1111\/bjd.12158","article-title":"Long-term (6 and 12 months) follow-up of two prospective, randomized, controlled phase III trials of photodynamic therapy with BF-200 ALA and methyl aminolaevulinate for the treatment of actinic keratosis","volume":"168","author":"Dirschka","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.16441-BIB0032|bjd16441-cit-0032","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1365-2133.2011.10613.x","article-title":"Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a multicentre, randomized, observer-blind phase III study in comparison with a registered methyl-5-aminolaevulinate cream and placebo","volume":"166","author":"Dirschka","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.16441-BIB0033|bjd16441-cit-0033","first-page":"2282","article-title":"5-Aminolevulinic acid-based photodynamic therapy","volume":"79","author":"Peng","year":"1997","journal-title":"Clinical research and future challenges. Cancer"},{"key":"10.1111\/bjd.16441-BIB0034|bjd16441-cit-0034","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S1470-2045(13)70143-8","article-title":"Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial","volume":"14","author":"Arits","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1111\/bjd.16441-BIB0035|bjd16441-cit-0035","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/jdv.12031","article-title":"European guidelines for topical photodynamic therapy part 1: treatment delivery and current indications - actinic keratoses, Bowen's disease, basal cell carcinoma","volume":"27","author":"Morton","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.16441","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/bjd.16441\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T13:39:45Z","timestamp":1676381985000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/179\/2\/309\/6730871"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,16]]},"references-count":35,"URL":"https:\/\/doi.org\/10.1111\/bjd.16441","archive":["Portico"],"relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5,16]]}}}